Almac Clinical Technologies today announces that it has been selected as winner of the “Best Clinical Trial Technology Solution Provider” award in the 10th annual MedTech Breakthrough Awards programme conducted by MedTech Breakthrough, an independent market intelligence organisation that recognises the most innovative companies, technologies and products in the global digital health and medical technology market.
Almac earned the recognition for not only its broad commitment to advancing clinical trial execution through integrated technology, operational expertise and global support capabilities, but also for the impact of the company’s breakthrough new platform, Almac Trial Coordinator™.
Almac Trial Coordinator™ was introduced in 2025, delivering a next-generation orchestration solution that unifies the operational journey of a clinical trial, bringing together tasks, data, systems, and people into a single, intuitive experience. It features a role-based, multi-modal interface that presents accurate information to the correct user at the right moment.
Sites have the ability to consolidate visit windows, patient status, eCOA compliance, drug accountability, and study tasks, while sponsors and CROs gain oversight through intelligent dashboards, alerts, and predictors, enabling proactive decision-making.
In line with Almac’s integrated approach to trial technology, Almac Trial Coordinator™ offers seamless interoperability with Almac’s global IRT platform and with third-party systems, ensuring real-time data synchronisation and equipping teams with up-to-date operational information wherever needed. Early deployments have shown reduced site burden, fewer protocol deviations, more consistent data collection, and enhanced oversight.
“Our years of Clinical Trial Technology delivery and support experience have informed every component of the platform - from user experience to compliance safeguards. Almac Trial Coordinator™ is reliable in environments where precision, auditability, and regulatory alignment matter most. We are delighted to be recognised by MedTech Breakthrough for the impact Almac Trial Coordinator will continue to have on crucial studies and the patients that rely on them,” said Valarie Higgins, President and Managing Director of Almac Clinical Technologies.
Now celebrating its 10th anniversary, the MedTech Breakthrough Awards program has spent a decade recognizing the companies driving meaningful progress and improving patient care across the global health and medical technology industry. The programme spans a wide range of categories – including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices and beyond – honoring the innovations reshaping how care is delivered worldwide.
This year's programme drew a record-breaking number of nominations from leading companies and startups across more than 20 countries, reflecting the growing global impact and momentum of the digital healthcare industry.
“Combining interoperability, automation, and user-centred design, Almac Trial Coordinator sets a new benchmark for how modern trials should be managed. The disconnect across individual technologies like eCOA, IRT, and more forces sites and study teams to rely on manual workarounds, duplicated data entry, and error-prone processes, slowing down studies, burdening sites, and complicating operational oversight,” said Steve Johansson, managing director, MedTech Breakthrough. “Almac Clinical Technologies delivers something genuinely transformative: a unified operational command centre designed to simplify, streamline, and elevate the clinical trial experience for all stakeholders. We’re pleased to award Almac Group with ‘Best Clinical Trial Technology Solution Provider!’”
About Almac Clinical Technologies
Almac Clinical Technologies delivers industry‑leading clinical trial technology and expertise, supporting sponsors and CROs with its Almac Trial Coordinator™ platform. Backed by decades of experience in clinical trial delivery, Almac combines deep therapeutic and operational expertise with advanced technology to support studies of all complexities. Designed to unify critical trial functions—including IRT, eCOA, eConsent, and participant and supply management—Almac Trial Coordinator™ provides a cohesive eClinical ecosystem that simplifies complexity and enhances trial execution. With a focus on compliance, precision, and reliability, Almac enables data‑driven decision‑making, global participant engagement, and streamlined management across sites, patients, and clinical supply.
About The Almac Group
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, analytical services, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation which has grown organically, now employing 7,200 highly skilled personnel across 18 facilities including Europe, the USA and Asia.
To keep up to date with latest news, follow us on X and LinkedIn or visit almacgroup.com.
About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.
Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
